FDA Approves First Oral Treatment for Postpartum Depression FDAgov

The FDA approved Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19.

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant…

The FDA approved Zepbound (tirzepatide) for chronic weight management in adults with obesity or are overweight.